Minocycline inhibits ICAD degradation and the NF-κB activation induced by 6-OHDA in PC12 cells.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Brain Research

• Publication date

  2014-10-24

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.brainres.2014.08.001PMID 25195972
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RETRACTED: 6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors.

  2013cited by this paper
• Neurotoxin-based models of Parkinson's disease.

  2012cited by this paper
• Tumor suppression in the absence of p53-mediated cell-cycle arrest, apoptosis, and senescence.

  2012cited by this paper
• Increased In Vitro Lysosomal Function in Oxidative Stress-Induced Cell Lines

  2011cited by this paper
• Protective effects of peony glycosides against corticosterone-induced cell death in PC12 cells through antioxidant action.

  2011cited by this paper
• The neuroprotective role of tissue inhibitor of metalloproteinase-2 in MPP+- or 6-OHDA-treated SK-N-BE(2)C and SH-SY5Y human neuroblastoma cells.

  2010cited by this paper
• Neurotoxic in vivo models of Parkinson's disease recent advances.

  2010cited by this paper
• Biomarkers of cell damage induced by oxidative stress in Parkinson's disease and related models.

  2010cited by this paper
• Metallocorroles as cytoprotective agents against oxidative and nitrative stress in cellular models of neurodegeneration

  2010cited by this paper
• Novel cell death signaling pathways in neurotoxicity models of dopaminergic degeneration: relevance to oxidative stress and neuroinflammation in Parkinson's disease.

  2010cited by this paper
• Mitochondria in neurodegenerative disorders: regulation of the redox state and death signaling leading to neuronal death and survival

  2009cited by this paper
• Caspase 3 is involved in the apoptosis induced by triptolide in HK-2 cells.

  2009cited by this paper
• Oxidative and nitrosative stress in Parkinson's disease.

  2009cited by this paper
• Cardiomyocyte H9c2 Cells Exhibit Differential Sensitivity to Intracellular Reactive Oxygen Species Generation with Regard to Their Hypertrophic vs Death Responses to Exogenously Added Hydrogen Peroxide

  2009cited by this paper
• Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis

  2008cited by this paper
• Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.

  2008cited by this paper
• ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes.

  2008cited by this paper
• Potentiation of Nerve Growth Factor-Induced Neurite Outgrowth by Fluvoxamine: Role of Sigma-1 Receptors, IP3 Receptors and Cellular Signaling Pathways

  2008cited by this paper
• Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by donepezil: role of sigma-1 receptors and IP3 receptors.

  2008cited by this paper
• Dopaminergic regeneration by neurturin-overexpressing c17.2 neural stem cells in a rat model of Parkinson's disease

  2007cited by this paper
• Iptakalim Alleviates Rotenone-Induced Degeneration of Dopaminergic Neurons through Inhibiting Microglia-Mediated Neuroinflammation

  2007cited by this paper
• Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells

  2007cited by this paper
• Susceptibility to rotenone is increased in neurons from parkin null mice and is reduced by minocycline

  2006cited by this paper
• The transcriptional targets of p53 in apoptosis control.

  2005cited by this paper
• Inhibition of thrombin‐induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo

  2005cited by this paper
• Bcl‐xL blocks mitochondrial multiple conductance channel activation and inhibits 6‐OHDA‐induced death in SH‐SY5Y cells

  2004cited by this paper
• The roles of dopamine transporter and Bcl-2 protein in the protection of CV1-P cells from 6-OHDA-induced toxicity.

  2004cited by this paper
• The promise of minocycline in neurology.

  2004cited by this paper
• High frequency of mitochondrial complex I mutations in Parkinson's disease and aging.

  2004cited by this paper
• Regeneration of Peroxiredoxins by p53-Regulated Sestrins, Homologs of Bacterial AhpD

  2004cited by this paper
• Minocycline prevents glutamate‐induced apoptosis of cerebellar granule neurons by differential regulation of p38 and Akt pathways

  2004cited by this paper
• Models of Parkinson's disease

  2003cited by this paper
• Minocycline blocks 6-hydroxydopamine-induced neurotoxicity and free radical production in rat cerebellar granule neurons.

  2003cited by this paper
• Caspase‐independent cell death by low concentrations of nitric oxide in PC12 cells: Involvement of cytochrome C oxidase inhibition and the production of reactive oxygen species in mitochondria

  2003cited by this paper
• p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells.

  2002cited by this paper
• Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway.

  2002cited by this paper
• Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury

  2002cited by this paper
• Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

  2002cited by this paper
• p 53 Mediates DNA Damaging Drug-induced Apoptosis through a Caspase-9-dependent Pathway in SH-SY 5 Y Neuroblastoma Cells 1

  2002cited by this paper
• Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

  2001influential reference
• Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease

  2001cited by this paper
• Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

  2001cited by this paper
• The DFF40/CAD endonuclease and its role in apoptosis.

  2000cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  2000cited by this paper
• Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

  2000cited by this paper
• Determinants of the Nuclear Localization of the Heterodimeric DNA Fragmentation Factor (Icad/Cad)

  2000cited by this paper
• Oxidative Stress, Mitochondrial Respiration, and Parkinson's Disease

  2000cited by this paper
• Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

  2000cited by this paper
• Structure of the heterodimeric complex between CAD domains of CAD and ICAD

  2000cited by this paper
• Glial cells and inflammation in parkinson's disease: A role in neurodegeneration?

  1998cited by this paper
• A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD

  1998cited by this paper
• Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis

  1998cited by this paper
• Understanding cell death in parkinson's disease

  1998cited by this paper
• Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum

  1997cited by this paper
• DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.

  1997cited by this paper
• Macromolecular substrates for the ICE‐like proteases during apoptosis

  1997cited by this paper
• Apoptosis in neurodegenerative disorders.

  1997cited by this paper
• Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease.

  1997cited by this paper
• Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequelae.

  1996cited by this paper
• Inhibition of mitochondrial complexes I and IV by 6-hydroxydopamine.

  1995cited by this paper
• The determination of hydroxydopamines and other trace amines in the urine of Parkinsonian patients and normal controls

  1993cited by this paper
• Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF‐kappa B transcription factor and HIV‐1.

  1991cited by this paper
• Pharmacotherapeutics of the newer tetracyclines.

  1980cited by this paper
• Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.

  1978cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper
• [Roland Richterich (1927-1973)].

  1974cited by this paper
• The generation of hydrogen peroxide, superoxide radical, and hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents.

  1974cited by this paper
• 6-Hydroxy-dopamine induced degeneration of central monoamine neurons.

  1968cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Antimicrobial drugs for Parkinson's disease: existing therapeutic strategies and novel drugs exploration.

  2024cites this paper
• Minocycline as a prospective therapeutic agent for cancer and non-cancer diseases: a scoping review

  2023cites this paper
• Therapeutic Strategies for Immune Transformation in Parkinson’s Disease

  2022cites this paper
• Minocycline Protects PC12 Cells Against Cadmium-Induced Neurotoxicity by Modulating Apoptosis

  2022cites this paper
• The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

  2022cites this paper
• Disease modifying therapies III: Novel targets.

  2021cites this paper
• Minocycline attenuates oxidative and inflammatory injury in a intestinal perforation induced septic lung injury model via down-regulating lncRNA MALAT1 expression.

  2021cites this paper
• New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota

  2021cites this paper
• Remodeling microglia to a protective phenotype in Parkinson's disease?

  2020cites this paper
• Kars region of Turkey: The role of computerized temporal tomography in diagnosis of tympanosclerosis

  2020cites this paper
• The therapeutic role of minocycline in Parkinson’s disease

  2019cites this paper
• The protective effects of the native flavanone flavanomarein on neuronal cells damaged by 6-OHDA.

  2019cites this paper
• Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds

  2017cites this paper
• Dopamine signaling and myopia development: What are the key challenges

  2017cites this paper
• Minocycline attenuates sevoflurane-induced cell injury via activation of Nrf2

  2017cites this paper
• Rhein exhibits antioxidative effects similar to Rhubarb in a rat model of traumatic brain injury

  2017cites this paper
• Selected gene profiles of stressed NSC-34 cells and rat spinal cord following peripheral nerve reconstruction and minocycline treatment

  2016cites this paper
• Minocycline Inhibits Inflammation and Squamous Metaplasia of Conjunctival Tissue Culture in Airlift Conditions

  2016cites this paper
• The Anti-Inflammatory Role of Minocycline in Alzheimer´s Disease.

  2016cites this paper
• Neurotoxin Mechanisms and Processes Relevant to Parkinson’s Disease: An Update

  2015influential citation
• Carcinogenicity assessment of the pan-caspase inhibitor, emricasan, in Tg.rasH2 mice.

  2015cites this paper